TY - JOUR
T1 - Diagnosing Human Papillomavirus of the Female Lower Genital Tract
T2 - Failure of the Pap Smear as a Sole Screening Test
AU - Lonky, Neal M.
AU - Mahoney, Antoinette
AU - Sauer, Mark V.
PY - 1991
Y1 - 1991
N2 - Of 197 patients referred for colposcopy who underwent repeat Pap smears and colposcopic biopsies (when indicated), histologic evidence of human papillomavirus (HPV) infection involving the endocervix, cervix, or vagina or all three sites was documented in 109 biopsies. Sixty-six (61%) had normal Pap smears at the time of colposcopy. Despite a specificity of 92% for detecting HPV, the Pap smear demonstrated a low sensitivity (39%), with a positive and negative predictive test value of 88% and 50%, respectively. In patients with biopsies revealing HPV infection without associated dysplasia, false negative Pap smears were found most often in women with strictly vaginal HPV (74%) (P < 0.05), followed by those with coexistent cervical and vaginal HPV (65%), and then by those with solely cervical HPV (51%). We question the use of the Pap smear for the detection of lower genital tract HPV, particularly in patients with only vaginal involvement, especially when the smear is repeated at the time of colposcopy. Benefits and disadvantages of other screening tests for HPV are discussed.
AB - Of 197 patients referred for colposcopy who underwent repeat Pap smears and colposcopic biopsies (when indicated), histologic evidence of human papillomavirus (HPV) infection involving the endocervix, cervix, or vagina or all three sites was documented in 109 biopsies. Sixty-six (61%) had normal Pap smears at the time of colposcopy. Despite a specificity of 92% for detecting HPV, the Pap smear demonstrated a low sensitivity (39%), with a positive and negative predictive test value of 88% and 50%, respectively. In patients with biopsies revealing HPV infection without associated dysplasia, false negative Pap smears were found most often in women with strictly vaginal HPV (74%) (P < 0.05), followed by those with coexistent cervical and vaginal HPV (65%), and then by those with solely cervical HPV (51%). We question the use of the Pap smear for the detection of lower genital tract HPV, particularly in patients with only vaginal involvement, especially when the smear is repeated at the time of colposcopy. Benefits and disadvantages of other screening tests for HPV are discussed.
UR - https://www.scopus.com/pages/publications/0026263725
UR - https://www.scopus.com/pages/publications/0026263725#tab=citedBy
U2 - 10.1089/gyn.1991.7.183
DO - 10.1089/gyn.1991.7.183
M3 - Article
C2 - 10150073
AN - SCOPUS:0026263725
SN - 1042-4067
VL - 7
SP - 183
EP - 189
JO - Journal of Gynecologic Surgery
JF - Journal of Gynecologic Surgery
IS - 3
ER -